[Treatment mapping of lower urinary tract symptoms due to benign prostatic hyperplasia-an analysis of the Governing Body of German Prostate Centers]. / Versorgungsabbild des benignen Prostatasyndroms eine Analyse des Dachverbandes der Prostatazentren Deutschlands (DVPZ) e.â¯V.
Urologe A
; 59(9): 1082-1091, 2020 Sep.
Article
em De
| MEDLINE
| ID: mdl-32274545
ABSTRACT
BACKGROUND:
Due to the high incidence and demographic development, there is an urgent need for healthcare research data on lower urinary tract symptoms due to benign prostatic hyperplasia (LTUS/BPH). Since 2005 the Governing Body of German Prostate Centers (DVPZ) has been collecting data from 22 prostate centers in order to determine the quality and type of cross-sectoral care in particular for LUTS/BPH patients.OBJECTIVES:
Presentation of the DVPZ database in general, as well as an investigation of treatment patterns for medical and instrumental therapies. MATERIALS ANDMETHODS:
The analysis is based on UroCloud data sets from 30 November 2017. In the UroCloud data on diagnostics, therapy and course of disease are recorded in a web-based manner.RESULTS:
A total of 29,555 therapies were documented for 18,299 patients (1.6/patient), divided into 48.5% instrumental, 29.2% medical treatment, and 18.0% "wait and see" (in 4.3% no assignment was possible). Patients treated with an instrumental therapy were oldest (median 72 years, interquartile range 66-77), had the largest prostate volumes (50â¯ml, 35-75â¯ml), and were mostly bothered by symptoms (International Prostate Symptom Scoreâ¯= 19/4). The majority of patients under medical treatment received alphablockers (56%); phytotherapeutics were used least frequently (3%). Instrumental therapies are dominated by transurethral resection (TUR) of the prostate (60.0%), open prostatectomy (9.4%) and laser therapy (5.0%), with laser therapy having the shortest hospital stay (5 days) and the lowest transfusion and re-intervention rates (1.0% and 4.6%, respectively).CONCLUSIONS:
The DVPZ certificate covers the complete spectrum of cross-sectoral care for LUTS/BPH patients and documents the use of the various therapies as well as their application and effectiveness in the daily routine setting.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Hiperplasia Prostática
/
Antagonistas Adrenérgicos alfa
/
Ressecção Transuretral da Próstata
/
Terapia a Laser
/
Sintomas do Trato Urinário Inferior
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Incidence_studies
/
Prognostic_studies
Limite:
Aged
/
Humans
/
Male
País/Região como assunto:
Europa
Idioma:
De
Revista:
Urologe A
Ano de publicação:
2020
Tipo de documento:
Article